Skip to main content
. 2015 May 11;10(5):e0125826. doi: 10.1371/journal.pone.0125826

Table 5. Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patients on anti-retroviral therapy (N = 1,321).

Variable Category Total, n Follow-up CD4 ≥350 % with follow-up CD4≥350 Chi square P value
Age in years 5–14 165 146 88.48 78.9601 0.000
>14 5076 2715 53.49
Gender Female 3330 2006 60.24 117.6648 0.000
Male 1911 855 44.74
WHO Stage I or II 2079 1193 57.38 10.8558 0.001
III or IV 3162 1668 52.75
Baseline CD4 cell count* <100 1569 512 32.63 568.0106 0.000
100–199 2224 1253 56.34
200–349 1300 983 75.62
>349 148 113 76.35

* Measured in cells/mm3.